Triple T Psychiatry

Triple T Psychiatry Our model of care is based on a holistic approach to primary care, behavioral health, and a focused treatment plan for optimal wellness.

At PMG, we offer integrated functional medicine. Our model of care is based on a holistic approach to primary care, behavioral health, an in-depth analysis, and a focused treatment plan for optimal wellness.We also currently offer COVID-19 rapid tests, PCR tests, and vaccinations.

09/10/2026

The WHO has issued updated emergency guidance on the possible use of Ervebo during the ongoing Ebola outbreak involving the Bundibugyo virus. The guidance, released September 1, addresses how an existing Ebola vaccine could potentially be used even though it was developed for a different Ebola species.

Ervebo is licensed for protection against Zaire ebolavirus, while the current outbreak involves Bundibugyo ebolavirus. The updated guidance focuses on how vaccination could fit into an emergency response where no licensed vaccine specifically targets the circulating strain.

09/09/2026

🚨 The Democratic Republic of Congo is facing the second-largest Ebola outbreak ever recorded, with 6,342 confirmed cases and 3,072 deaths reported as of September 3. The outbreak is being driven by the rare Bundibugyo strain, which currently has no approved vaccine or treatment specifically targeting that strain.

The outbreak has spread across multiple provinces, including and , while health agencies continue working to contain transmission. The WHO says the epidemic is moving faster than any previous Ebola outbreak.

More than 1,700 Doctors Without Borders staff are reportedly involved in the response.

09/09/2026

The FDA has issued an Emergency Use Authorization for drugs to prevent and treat New World screwworm infestations in dogs and cats as the parasite continues spreading north.

New World screwworm is a parasitic fly whose larvae can infest the tissue of animals, creating a serious threat to animal health. The FDA announced the emergency authorization on September 3, 2026, as officials respond to the growing concern.

09/08/2026

The FDA has approved Zanvastro (zilganersen) as the first FDA-approved treatment for Alexander disease, a rare and progressive neurological disorder affecting both children and adults. The approval was announced on September 3, 2026.

Unlike previous care, which focused mainly on managing symptoms, Zanvastro is designed to target the abnormal GFAP protein buildup linked to the disease.

Alexander disease affects fewer than 1 in 1 million people, and the new treatment marks the first FDA-approved therapy aimed at its underlying cause.

09/08/2026

A Dallas-area clinic has agreed to pay $7.5 million to resolve allegations that it improperly billed the government for COVID-19 testing. Aymancare PLLC operated pop-up sites offering free COVID tests through a federal program for uninsured patients.

Investigators alleged the clinic billed separately for evaluation-and-management visits even when a technician only performed the nasal swab. The settlement resolves False Claims Act allegations and does not represent a determination of liability.

09/08/2026

Two Florida men have been sentenced to federal prison for their roles in a $34.8 million Medicare fraud conspiracy involving thousands of orthotic braces. Prosecutors say the scheme targeted by billing for braces that beneficiaries allegedly did not need.

The case highlights how fraudulent medical equipment orders can generate millions in improper Medicare payments. Federal authorities, including CMS and HHS-OIG, continue investigating and prosecuting healthcare fraud schemes.

09/07/2026

Federal prosecutors say they have charged what the Justice Department describes as its largest-ever healthcare fraud case, involving more than $1.3 billion in allegedly fraudulent claims submitted over just five months. Massachusetts prosecutors indicted Erekle Gugava on a money-laundering conspiracy charge tied to a Pennsylvania durable medical equipment company. Prosecutors allege the company submitted claims to Medicare, Medicare supplemental insurers, and private health plans between February and July 2025, with proceeds allegedly funneled to a Russia-based criminal network. The case is based on an indictment, and Gugava is presumed innocent unless proven guilty.

09/06/2026

Monogram Health has agreed to pay $2.4 million to resolve allegations that it caused inaccurate diagnosis codes to be submitted to Medicare Advantage, potentially increasing payments to health plans. The Justice Department says accurate diagnosis coding is critical because Medicare Advantage payments are partly based on the health conditions documented for beneficiaries. Monogram Health settled the case without a determination of liability.

09/05/2026

A Chicago-area medical practice and billing companies are facing a $5.2 million False Claims Act lawsuit over allegedly fraudulent Medicare and Medicaid claims. Federal and Illinois authorities allege the defendants submitted claims involving podiatry services even after one physician had been terminated from the Medicaid program. The government is seeking damages and civil penalties, but the case remains a civil allegation and there has been no finding of liability.

09/05/2026

🚨 The FDA has expanded approval of Stelara (ustekinumab) for pediatric patients with moderately to severely active ulcerative colitis, giving children another treatment option when existing therapies are not enough. The medicine targets specific immune pathways involved in inflammation and has already been used to treat ulcerative colitis in adults. The expanded approval extends its use to eligible pediatric patients.

Address

7426 N La Cholla Boulevard
Cortaro, AZ
85741

Opening Hours

Monday 8am - 4pm
Tuesday 8am - 4pm
Wednesday 8am - 4pm
Thursday 8am - 4pm
Friday 8am - 4pm

Alerts

Be the first to know and let us send you an email when Triple T Psychiatry posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Triple T Psychiatry:

Shortcuts

Share